Combinatorial BCL-2 family expression in Acute Myeloid Leukemia Stem Cells predicts clinical response to Azacitidine/Venetoclax

Overview of attention for article published in Cancer Discovery, March 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news: 7 news outlets
blogs: 1 blog

twitter: 55 X users

Citations

dimensions_citation: 24 Dimensions

Readers on

mendeley: 52 Mendeley

Summary News Blogs X Dimensions citations

So far, Altmetric has seen 7 news stories from 7 outlets.

Langzeitergebnisse bei Mamma-, beim Prostata- und beim Magenkarzinom

Medscape, 21 Mar 2023

Im Onko-Blog dieser Woche geht es unter anderem um Langzeitergebnisse bei Mamma-, Prostata- und Magenkarzinom.

Scientists develop a marker for therapy response in acute myeloid leukemia

Health Reporter, 18 Mar 2023

Scientists develop a marker for therapy response in acute myeloid leukemia

The Medical News, 17 Mar 2023

With the combination of the drugs Venetoclax and 5-Azacitidine, a new, effective and more tolerable alternative to chemotherapy…

Marker for therapy response in AML identified - ecancer

ecancer, 17 Mar 2023

With the combination of the drugs Venetoclax and 5-Azacitidine, a new, effective and more tolerable alternative to chemotherapy…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 3 additional news stories.